Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
NCT ID:
NCT03211416
Group ID:
EG000
Title:
Treatment (Sorafenib Tosylate, Pembrolizumab)
Description:
Patients receive sorafenib tosylate PO BID on days -28 to -1 and 1-21. Patients also receive pembrolizumab IV over 30 minutes on day 1. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.
Laboratory Biomarker Analysis: Correlative studies
Pembrolizumab: Given IV
Sorafenib Tosylate: Given PO
Deaths Number Affected:
24
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
37
Other Number Affected:
36
Other Number At Risk:
37
Study:
NCT03211416
Results Section:
NCT03211416
Adverse Events Module:
NCT03211416